This panel will discuss ongoing challenges and questions surrounding FDA decision-making, authority, and trustworthiness. Discussion will include recent cases, including Alliance for Hippocratic Medicine v. FDA, about access to mifepristone, and litigation filed by state Attorneys General.
Speakers will include:
Tom Bollyky: Senior Fellow, Global Health, Economics, and Development and Director, Global Health Program, Council on Foreign Relations
Aaron Kesselheim, M.D.: Professor of Medicine Harvard Medical School; Visiting Professor of Law, Solomon Center for Health Law and Policy, Yale Law School
Reshma Ramachandran, M.D.: Assistant Professor of Medicine and Co-Director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine
Joshua Sharfstein, M.D.: Vice Dean for Public Health Practice and Community Engagement and Professor of the Practice, Johns Hopkins Bloomberg School of Public Health
Zoom option available: Register here
Non-pizza lunch will be provided.
Sponsoring Organization(s)
The Solomon Center for Health Law and Policy, Yale Health Law and Policy Society (YHeLPS)